Dergiler / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 9

Relationship between the presence of left atrial thrombus in patients with mitral stenosis and platelet-to-lymphocyte ratio

Sayfa
673–677
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Higher PLR was identified as independently associated with the presence of LA thrombus (odds ratio: 1.03, 95% confidence interval: 1-1.06, p=0.016).Conclusion: Higher PLR was detected in the LA thrombus group of patients with RMVS

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Rheumatic carditis-induced mitral valve disease is associated with a chronic inflammatory process.
📊
Temel Bulgular & Veri:Our goal was to examine the relationship between the presence of left atrial (LA) thrombus in patients with rheumatic mitral valve stenosis (RMVS) and platelet-to-lymphocyte ratio (PLR), which is an inflammatory marker.Methods: This cross-sectional study included 351 consecutive patients diagnosed with RMVS upon presentation to the cardiology polyclinic.
💡
Sonuç & Katkı:Higher PLR was identified as independently associated with the presence of LA thrombus (odds ratio: 1.03, 95% confidence interval: 1-1.06, p=0.016).Conclusion: Higher PLR was detected in the LA thrombus group of patients with RMVS
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Rheumatic carditis-induced mitral valve disease is associated with a chronic inflammatory process. The close relationship between inflammation and prothrombotic processes is known. Our goal was to examine the relationship between the presence of left atrial (LA) thrombus in patients with rheumatic mitral valve stenosis (RMVS) and platelet-to-lymphocyte ratio (PLR), which is an inflammatory marker.Methods: This cross-sectional study included 351 consecutive patients diagnosed with RMVS upon presentation to the cardiology polyclinic. All patients were evaluated using transthoracic and transesophageal echocardiography and were divided into 2 groups: those with and without LA thrombus. In addition to echocardiographic and biochemical parameters, PLR was compared between the groups. Student's t-test, Mann-Whitney U test, logistic regression analysis, and receiver operating characteristic (ROC) curve analysis were used for statistical analysis.Results: No significant differences in terms of age, gender, body mass index, and comorbidities were found between the groups with and without LA thrombus. In the group with LA thrombus, higher red cell distribution width, mean platelet volume, and platelet count and lower lymphocyte count were detected. In addition, C-reactive protein levels were significantly higher in the LA thrombus group (4.7 vs. 2.7 mg/L, p<0.001). PLR was significantly higher in patients with thrombus than in those without (133±38 vs. 119±31, p=0.001). Higher PLR was identified as independently associated with the presence of LA thrombus (odds ratio: 1.03, 95% confidence interval: 1-1.06, p=0.016).Conclusion: Higher PLR was detected in the LA thrombus group of patients with RMVS

🔖

Bu Makaleye Atıf Yap

BELEN, E., ÖZAL, E., PÜŞÜROĞLU, H. (2016). Relationship between the presence of left atrial thrombus in patients with mitral stenosis and platelet-to-lymphocyte ratio. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 9, 673–677. https://ajindex.com/articles/365432

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Stollerman GH. Rheumatic fever. Lancet 1997; 349: 935-42.
  2. Fleming HA, Bailey SM. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 1971; 47: 599-604.
  3. Gölbaşı Z, Uçar O, Keleş T, Şahin A, Çağlı K, Çamsarı A, et al. In- creased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflamma- tion. Eur J Heart Fail 2002; 4: 593-5.
  4. Chiu-Braga YY, Hayashi SY, Schafranski M, Messias-Reason IJ. Further evidence of inflammation in chronic rheumatic valve dis- ease (CRVD): high levels of advanced oxidation protein products (AOPP) and high sensitive C-reactive protein (hs-CRP). Int J Cardiol 2006; 109: 275-6.
  5. Akpek M, Kaya MG, Yarlıoglues M, Doğdu O, Ardiç I, Şahin O, et al. Relationship between platelet indices and spontaneous echo contrast in patients with mitral stenosis. Eur J Echocardiogr 2011; 12: 865-70.
  6. Yüce M, Çakıcı M, Davutoğlu V, Özer O, Sarı I, Ercan S, et al. Re- lationship between mean platelet volume and atrial thrombus in patients with atrial fibrillation. Blood Coagul Fibrinolysis 2010; 21: 722-5.
  7. Conway DS, Buggins P, Hughes E, Lip GY. Relationship of interleu- kin- 6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 2004; 43: 2075-82.
  8. Sünbül M, Gerin F, Durmuş E, Kıvrak T, Sarı I, Tigen K, et al. Neutro- phil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens 2014; 36: 217-21.
  9. Açar G, Kalkan ME, Avcı A, Alizade E, Tabakçı MM, Toprak C, et al. The relation of platelet-lymphocyte ratio and coronary collateral circulation in patients with stable angina pectoris and chronic total occlusion. Clin Appl Thromb Hemost 2015; 21: 462-8.
  10. Gary T, Pichler M, Belaj K, Hafner F, Gerger A, Froehlich H, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb isch- emia in peripheral arterial occlusive disease patients. PLoS One 2013; 8: e67688. Hess K, Grant PJ. Inflammation and thrombosis in diabetes. Thromb Haemost 2011; 105: 43-54.
  11. Kaya MG, Yarlioglues M, Günebakmaz O, Güntürk E, Inanç T, Doğan A, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209: 278-82.
  12. Balta S, Demirkol S, Küçük U. The platelet lymphocyte ratio may be useful inflammatory indicator in clinical practice. Hemodial Int 2013; 17: 668-9.
  13. Waehre T, Damås JK, Yndestad A, Taskén K, Pedersen TM, Smith C, et al. Effe